Pharmacokinetic Dose Guidance of IV Busulfan with Fludarabine with Allogeneic Stem Cell Transplantation Improves Progression Free Survival in Patients with AML and MDS; Results of a Randomized Phase III Study
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Authors: Borje S Andersson, Marcos J de Lima, Rima M Saliba, Elizabeth J Shpall, Uday Popat, Roy Jones, Yago Nieto, Chitra M Hosing, Partow Kebriaei, Amin M Alousi, Laura L. Worth, Timothy Madden, Alison Gulbis, Julianne J Chen, Gabriela Rondon, Patricia McAdams, Becky McMullin, Michael Andreeff, Richard Champlin
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2558768706